Another finding shows that miR-17 promotes OC tumorigenesis and pathological manifestations including stemness features and the development of ovarian CSCs from normal ovarian cancer cells by targeting the LKB1-p53-p21/WAF1 signaling pathway [121]. This evidence concerns the gene CDKN1A and ovarian cancer.